171 related articles for article (PubMed ID: 18161742)
1. Chiral-catalyst-based convergent synthesis of HIV protease inhibitor GRL-06579A.
Mihara H; Sohtome Y; Matsunaga S; Shibasaki M
Chem Asian J; 2008 Feb; 3(2):359-66. PubMed ID: 18161742
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.
Ghosh AK; Sridhar PR; Leshchenko S; Hussain AK; Li J; Kovalevsky AY; Walters DE; Wedekind JE; Grum-Tokars V; Das D; Koh Y; Maeda K; Gatanaga H; Weber IT; Mitsuya H
J Med Chem; 2006 Aug; 49(17):5252-61. PubMed ID: 16913714
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.
Quaedflieg PJ; Kesteleyn BR; Wigerinck PB; Goyvaerts NM; Vijn RJ; Liebregts CS; Kooistra JH; Cusan C
Org Lett; 2005 Dec; 7(26):5917-20. PubMed ID: 16354099
[TBL] [Abstract][Full Text] [Related]
4. Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease.
Kar P; Knecht V
J Phys Chem B; 2012 Mar; 116(8):2605-14. PubMed ID: 22280246
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective photochemical 1,3-dioxolane addition to 5-alkoxymethyl-2(5H)-furanone: synthesis of bis-tetrahydrofuranyl ligand for HIV protease inhibitor UIC-94017 (TMC-114).
Ghosh AK; Leshchenko S; Noetzel M
J Org Chem; 2004 Nov; 69(23):7822-9. PubMed ID: 15527257
[TBL] [Abstract][Full Text] [Related]
6. Application of the Lewis acid-Lewis base bifunctional asymmetric catalysts to pharmaceutical syntheses: stereoselective chiral building block syntheses of human immunodeficiency virus (HIV) protease inhibitor and beta3-adenergic receptor agonist.
Nogami H; Kanai M; Shibasaki M
Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):702-9. PubMed ID: 12808250
[TBL] [Abstract][Full Text] [Related]
7. Stereodivergent catalytic doubly diastereoselective nitroaldol reactions using heterobimetallic complexes.
Sohtome Y; Kato Y; Handa S; Aoyama N; Nagawa K; Matsunaga S; Shibasaki M
Org Lett; 2008 Jun; 10(11):2231-4. PubMed ID: 18465868
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric total synthesis of bacillariolide III, a marine oxylipin.
Seo SY; Jung JK; Paek SM; Lee YS; Kim SH; Lee KO; Suh YG
Org Lett; 2004 Feb; 6(3):429-32. PubMed ID: 14748610
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective syntheses of pachastrissamine and jaspine A via hydroxylactonization of a chiral epoxy ester.
Urano H; Enomoto M; Kuwahara S
Biosci Biotechnol Biochem; 2010; 74(1):152-7. PubMed ID: 20057132
[TBL] [Abstract][Full Text] [Related]
11. Rh(I)-catalyzed ring-opening of hetaryne-furan Diels-Alder adducts: rapid access to stereochemically defined heterocyclic scaffolds.
Nguyen TD; Webster R; Lautens M
Org Lett; 2011 Mar; 13(6):1370-3. PubMed ID: 21348505
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in asymmetric bifunctional catalysis using multimetallic systems.
Shibasaki M; Kanai M; Matsunaga S; Kumagai N
Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320
[TBL] [Abstract][Full Text] [Related]
13. Polymer-supported bisBINOL ligands for the immobilization of multicomponent asymmetric catalysts.
Sekiguti T; Iizuka Y; Takizawa S; Jayaprakash D; Arai T; Sasai H
Org Lett; 2003 Jul; 5(15):2647-50. PubMed ID: 12868880
[TBL] [Abstract][Full Text] [Related]
14. Antibody-catalyzed asymmetric intramolecular Michael addition of aldehydes and ketones to yield the disfavored cis-product.
Weinstain R; Lerner RA; Barbas CF; Shabat D
J Am Chem Soc; 2005 Sep; 127(38):13104-5. PubMed ID: 16173712
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of the carbocyclic skeleton of abyssomicins C and D.
Snider BB; Zou Y
Org Lett; 2005 Oct; 7(22):4939-41. PubMed ID: 16235927
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective Black rearrangement catalyzed by chiral bicyclic imidazole.
Wang M; Zhang Z; Liu S; Xie F; Zhang W
Chem Commun (Camb); 2014 Feb; 50(10):1227-30. PubMed ID: 24336514
[TBL] [Abstract][Full Text] [Related]
17. Oximinoarylsulfonamides as potent HIV protease inhibitors.
Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of all four stereoisomers of 3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid.
Bakonyi B; Furegati M; Kramer C; La Vecchia L; Ossola F
J Org Chem; 2013 Sep; 78(18):9328-39. PubMed ID: 23957679
[TBL] [Abstract][Full Text] [Related]
19. GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
Koh Y; Das D; Leschenko S; Nakata H; Ogata-Aoki H; Amano M; Nakayama M; Ghosh AK; Mitsuya H
Antimicrob Agents Chemother; 2009 Mar; 53(3):997-1006. PubMed ID: 18955518
[TBL] [Abstract][Full Text] [Related]
20. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
